Publications

Division/Center

The Impact of State Medical Malpractice Reform on Individual-Level Health Care Expenditures

Health Serv Res
Yu H, Greenberg M, Haviland A

Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.

Breast Cancer Res. Treat.
Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL

The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.

Implement Sci
Worthington HC, Cheng L, Majumdar SR, Morgan SG, Raymond CB, Soumerai SB, Law MR

Long-Term Impact of a Postdischarge Community Health Worker Intervention on Health Care Costs in a Safety-Net System.

Health Serv Res
Galbraith AA, Meyers DJ, Ross-Degnan D, Burns ME, Vialle-Valentin CE, Larochelle MR, Touw S, Zhang F, Rosenthal M, Balaban RB

Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients.

J Pers Med
Wu AC, Mazor KM, Ceccarelli R, Loomer S, Lu CY

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).

Br. J. Cancer
Daniels B, Kiely BE, Houssami N, Lord SJ, Dobbins T, Lu CY, Ward RL, Pearson SA

Association between the 2012 Health and Social Care Act and specialist visits and hospitalisations in England: A controlled interrupted time series analysis.

PLoS Med.
Lopez Bernal JA, Lu CY, Gasparrini A, Cummins S, Wharham JF, Soumerai SB

The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China.

BMC Health Serv Res
Guo Z, Guan X, Shi L

State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015.

Value Health
Lu CY, Zhang F, Golonski N, Lupton C, Jeffrey P, Wagner AK

Retrospective interrupted time series examining hypertension and diabetes medicines usage following changes in patient cost sharing in the 'Farmácia Popular' programme in Brazil.

BMJ Open
Emmerick ICM, Campos MR, Luiza VL, Chaves LA, Bertoldi AD, Ross-Degnan D

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.

Breast Cancer Res. Treat.
Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA

Competency in supportive supervision: a study of public sector medicines management supervisors in Uganda.

J Pharm Policy Pract
Henry R, Nantongo L, Wagner AK, Embrey M, Trap B

Emerging Trends in Family History of Breast Cancer and Associated Risk.

Cancer Epidemiol. Biomarkers Prev.
Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A

The effect of Medicaid expansion on crime reduction: Evidence from HIFA-waiver expansions

J Public Econ
WenH, Hockenberry JM, Cumming JR

A group randomized trial using an appointment system to improve adherence to ART at reproductive and child health clinics implementing Option B+ in Tanzania.

PLoS ONE
Ross-Degnan D, Chalker J, Liana J, Kajoka MD, Valimba R, Kimatta S, Dillip A, Vialle-Valentin C, Embrey M, Lieber R, Johnson K

The value of innovation in decision-making in health care in Central Eastern Europe-The Sixth International Conference: The value of innovation in decision-making in health care in Central Eastern Europe, 2 June 2017, Belgrade, Serbia.

Expert Rev Pharmacoecon Outcomes Res
Novakovic T, Martin AP, Parker M, Ferrario A, Vukovic S, Łanda K, Duba J, Dankó D, Kotsopoulos N, Godman B, Ristic J, Stefanovic D, Tesic D

Clinician-Level Predictors for Ordering Low-Value Imaging.

JAMA Intern Med
Hong AS, Ross-Degnan D, Zhang F, Wharam JF

The Impact of FDA Regulatory Activities on Incident Dispensing of LABA-Containing Medication: 2005-2011.

J Asthma
Baker MA, Butler MG, Seymour S, Zhang F, Wu Y, Wu AC, Levenson MS, Wu P, Iyer A, Toh S, Iyasu S, Zhou EH

Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.

JAMA Cardiol
Kazi DS, Lu CY, Lin GA, DeJong C, Dudley RA, Chen R, Tseng CW

Did the dependent coverage expansion increase risky substance use among young adults?

Drug Alcohol Depend
Breslau J, Yu H, Han B, Pacula RL, Burns RM, Stein BD